Skip to content

Dyspepsia - Buspiron.

Does buspiron induce a raised prolactin response in functional dyspeptics?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20895
Enrollment
20
Registered
2005-05-31
Start date
2005-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Single dose of Buspiron (30 mg).

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers: absence of gastrointestinal symptoms, Nepean Dyspepsia Index (NDI) score 18 years of age. Patients: Nepean Dyspepsia Index (NDI) score >25, > 18 years of age.

Exclusion criteria

Exclusion criteria: Healthy volunteers: use of drugs that affect gastrointestinal motility (antidepressants, opiates, NSAID’s, calcium-blockers, nitrates), previous abdominal surgery, epilepsy, severe liver of renal insufficience, depression, claustrophobia, metal implants, not be able to lie down for 15 minutes. Patients: use of drugs that affect gastrointestinal motility (antidepressants, opiates, NSAID’s, calcium-blockers, nitrates), IBS, previous abdominal surgery, epilepsy, severe liver of renal insufficience, depression, claustrophobia, metal implants, not be able to lie down for 15 minutes.

Contacts

Public ContactG.E.E. Boeckxstaens

Academic Medical Center (AMC), Department of Gastroenterology, C2-328, P.O. Box 22660

g.e.boeckxstaens@amc.uva.nl+31 (0)20 5667375

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)